UBS raised the firm’s price target on Li-Cycle (LICY) to $2.25 from $2 and keeps a Neutral rating on the shares post the Q3 report.
UBS raised the firm’s price target on Li-Cycle (LICY) to $2.25 from $2 and keeps a Neutral rating on the shares post the Q3 report.